Biomarkers in ACS play an important role in identifying heart muscle injury and supporting the diagnosis and risk assessment of acute coronary syndrome (ACS). Among the available cardiac biomarkers, cardiac troponin—particularly high-sensitivity cardiac troponin (hs-cTn)—is central to the modern evaluation of patients with suspected ACS.
What Is Acute Coronary Syndrome?
Acute coronary syndrome is a group of conditions caused by a sudden reduction in blood flow to the heart muscle. It includes unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI).
Symptoms may include chest discomfort, breathlessness, sweating, nausea, or pain spreading to the arm, shoulder, jaw, or back. Because symptoms can vary, clinical assessment is combined with an electrocardiogram (ECG) and blood tests.
What Are Biomarkers in ACS?
Biomarkers in ACS are measurable substances in the blood that can provide evidence of myocardial injury. The most clinically important biomarker is cardiac troponin, a protein released into the bloodstream when heart muscle cells are damaged.
The two major forms used clinically are cardiac troponin I and cardiac troponin T. Modern high-sensitivity cardiac troponin assays can detect much smaller concentrations of troponin than earlier tests, allowing clinicians to identify myocardial injury earlier and more accurately.
However, an elevated troponin concentration does not automatically mean that a patient has had a heart attack. Troponin can also rise in conditions such as heart failure, myocarditis, pulmonary embolism, kidney disease, severe infection, or sustained rapid heart rhythms. Therefore, results must be interpreted alongside symptoms, ECG findings, medical history, imaging, and changes in troponin levels over time.
Why Is High-Sensitivity Troponin Important?
High-sensitivity cardiac troponin has become an important component of acute coronary syndrome diagnosis. It can detect low concentrations of cardiac troponin and help clinicians identify or rule out myocardial infarction more efficiently.
Instead of relying only on a single blood test, clinicians commonly assess the troponin concentration at presentation and, when appropriate, repeat it after a defined interval. The change between measurements—often referred to as the delta troponin—can provide additional information about an acute process.
This approach is particularly relevant to the diagnosis of NSTEMI, where there may be no persistent ST-segment elevation on the ECG.
High-Sensitivity Troponin Algorithms
High-sensitivity troponin algorithms use specific hs-cTn measurements and changes over time to help classify patients with suspected ACS. Depending on the assay and clinical setting, protocols may use very early measurements followed by repeat testing after a short interval.
A troponin algorithm can help place patients into broad clinical categories, such as:
- Patients in whom acute myocardial infarction can be ruled out.
- Patients who require additional observation and testing.
- Patients with findings that support an acute myocardial infarction and require urgent management.
The exact thresholds and timing vary according to the specific assay, laboratory, clinical protocol, and patient characteristics. Therefore, hs-cTn results should not be interpreted independently.
Troponin for Acute Coronary Syndrome
Troponin for acute coronary syndrome is valuable because it provides objective evidence of myocardial injury. A rise and/or fall in cardiac troponin, together with clinical evidence of myocardial ischemia, is central to diagnosing acute myocardial infarction.
It is important to distinguish myocardial injury from myocardial infarction. An elevated hs-cTn level indicates myocardial injury, while myocardial infarction requires evidence that the injury is related to myocardial ischemia.
This distinction helps prevent overdiagnosis and ensures that patients receive an appropriate evaluation for the underlying cause.
Other ACS Biomarkers
Although cardiac troponin is the preferred biomarker for suspected myocardial infarction, researchers have studied several other ACS biomarkers, including creatine kinase-MB and myoglobin.
Creatine kinase-MB has historically been used to detect myocardial injury but is less specific than cardiac troponin. Myoglobin can rise early after muscle injury but lacks cardiac specificity. For these reasons, contemporary clinical practice generally places cardiac troponin at the center of biomarker-based assessment.
How Are Biomarkers Used With Other Tests?
A reliable acute coronary syndrome diagnosis does not depend on biomarkers alone. Healthcare professionals consider several factors together:
- Symptoms and medical history – The nature, duration, and associated features of chest discomfort are assessed.
- ECG – An ECG can identify ischemic changes and may immediately indicate STEMI.
- hs-cTn testing Initial and repeat measurements help assess myocardial injury.
- Clinical examination: Blood pressure, heart rate, oxygenation, and other findings provide additional information.
- Imaging and coronary evaluation: Echocardiography, coronary CT angiography, or invasive coronary angiography may be considered when clinically appropriate.
This combined approach is particularly important because a normal initial troponin result does not always exclude ACS when testing occurs very early after symptom onset.
When Should Medical Attention Be Sought?
New or unexplained chest pressure, severe breathlessness, fainting, cold sweating, or discomfort spreading to the arm, jaw, shoulder, or back may indicate a serious cardiac problem. Such symptoms require urgent medical assessment rather than relying on an online explanation or waiting for symptoms to resolve.
Early evaluation can allow clinicians to perform an ECG and appropriate blood tests, including hs-cTn, and determine whether further emergency treatment is required.
Conclusion
Biomarkers in ACS, particularly hs-cTn, have transformed the assessment of suspected acute coronary syndrome. High-sensitivity cardiac troponin allows clinicians to detect myocardial injury at lower concentrations and use structured high-sensitivity troponin algorithms to support rapid clinical decision-making.
Nevertheless, troponin results must always be interpreted in context. Symptoms, ECG findings, serial measurements, medical history, and other investigations remain essential for accurate diagnosis and appropriate treatment.
For expert evaluation of suspected coronary disease or acute cardiac symptoms, consultation with a qualified specialist such as the best cardiologist in Hyderabad can help ensure timely and appropriate cardiac assessment.
For cardiac consultation and evaluation, contact Dr. C. Raghu, Clinical Director & Senior Interventional Cardiologist at Yashoda Hospitals, Secunderabad.
Click here for more information on YouTube: https://youtu.be/zhvamAmo3JA?si=sV8GaWWPjUA8Cjhj
Important: This article on biomarkers in ACS is intended for general educational and informational purposes only and does not replace professional medical advice, diagnosis, or treatment. If you or someone around you develops symptoms suggestive of a heart attack, such as chest pain or pressure, severe breathlessness, sweating, nausea, or pain spreading to the arm, jaw, shoulder, or back, seek emergency medical care immediately.
